News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,703 Results
Type
Article (56940)
Company Profile (210)
Press Release (629553)
Section
Business (198361)
Career Advice (2082)
Deals (32977)
Drug Delivery (75)
Drug Development (77000)
Employer Resources (150)
FDA (15056)
Job Trends (14155)
News (328547)
Policy (27023)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (9)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (13)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (4)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (3)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2817)
Academic (1)
Accelerated approval (3)
Adcomms (12)
Allergies (69)
Alliances (50817)
ALS (84)
Alzheimer's disease (1348)
Antibody-drug conjugate (ADC) (120)
Approvals (15091)
Artificial intelligence (252)
Autoimmune disease (17)
Automation (14)
Bankruptcy (292)
Best Places to Work (11165)
BIOSECURE Act (19)
Biosimilars (76)
Biotechnology (138)
Bladder cancer (59)
Brain cancer (26)
Breast cancer (241)
Cancer (1988)
Cardiovascular disease (147)
Career advice (1770)
Career pathing (26)
CAR-T (135)
Cell therapy (379)
Cervical cancer (17)
Clinical research (61941)
Collaboration (797)
Compensation (324)
Complete response letters (15)
COVID-19 (2370)
CRISPR (35)
C-suite (218)
Cystic fibrosis (91)
Data (1914)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (213)
Diagnostics (6135)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (36)
Drug discovery (114)
Drug pricing (78)
Drug shortages (15)
Duchenne muscular dystrophy (74)
Earnings (78561)
Editorial (32)
Employer branding (19)
Employer resources (129)
Events (103466)
Executive appointments (665)
FDA (16121)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (695)
Gene editing (90)
Generative AI (20)
Gene therapy (259)
GLP-1 (598)
Government (3194)
Grass and pollen (4)
Guidances (44)
Healthcare (17686)
Huntington's disease (19)
IgA nephropathy (24)
Immunology and inflammation (95)
Indications (26)
Infectious disease (2495)
Inflammatory bowel disease (120)
Inflation Reduction Act (10)
Influenza (46)
Intellectual property (90)
Interviews (370)
IPO (14753)
IRA (38)
Job creations (3420)
Job search strategy (1538)
Kidney cancer (7)
Labor market (29)
Layoffs (420)
Leadership (12)
Legal (5896)
Liver cancer (67)
Lung cancer (312)
Lymphoma (126)
Machine learning (3)
Management (52)
Manufacturing (257)
MASH (55)
Medical device (13054)
Medtech (13058)
Mergers & acquisitions (18714)
Metabolic disorders (529)
Multiple sclerosis (71)
NASH (14)
Neurodegenerative disease (82)
Neuropsychiatric disorders (21)
Neuroscience (1819)
NextGen: Class of 2025 (6099)
Non-profit (4381)
Northern California (2200)
Now hiring (27)
Obesity (257)
Opinion (213)
Ovarian cancer (73)
Pain (75)
Pancreatic cancer (74)
Parkinson's disease (132)
Partnered (21)
Patents (193)
Patient recruitment (93)
Peanut (39)
People (57928)
Pharmaceutical (54)
Pharmacy benefit managers (13)
Phase I (19685)
Phase II (27028)
Phase III (19988)
Pipeline (1047)
Podcasts (53)
Policy (101)
Postmarket research (2626)
Preclinical (8945)
Press Release (71)
Prostate cancer (88)
Psychedelics (26)
Radiopharmaceuticals (246)
Rare diseases (329)
Real estate (5995)
Recruiting (60)
Regulatory (19675)
Reports (35)
Research institute (2585)
Resumes & cover letters (281)
Rett syndrome (4)
RNA editing (3)
RSV (34)
Schizophrenia (63)
Series A (120)
Series B (76)
Service/supplier (16)
Sickle cell disease (48)
Southern California (1928)
Special edition (15)
Spinal muscular atrophy (140)
Sponsored (29)
Startups (3498)
State (1)
Stomach cancer (9)
Supply chain (53)
Tariffs (8)
The Weekly (34)
United States (19877)
Vaccines (601)
Venture capitalists (32)
Webinars (13)
Weight loss (161)
Women's health (28)
Worklife (16)
Date
Today (98)
Last 7 days (626)
Last 30 days (2550)
Last 365 days (31717)
2025 (7902)
2024 (33353)
2023 (38291)
2022 (49044)
2021 (53060)
2020 (51152)
2019 (44809)
2018 (33890)
2017 (31247)
2016 (31997)
2015 (38041)
2014 (29496)
2013 (25327)
2012 (29683)
2011 (29700)
2010 (29141)
Location
Africa (802)
Alabama (49)
Alaska (6)
Arizona (219)
Arkansas (13)
Asia (40257)
Australia (6837)
California (5061)
Canada (1772)
China (478)
Colorado (239)
Connecticut (264)
Delaware (133)
Europe (92682)
Florida (766)
Georgia (184)
Idaho (57)
Illinois (509)
India (23)
Indiana (284)
Iowa (8)
Japan (145)
Kansas (91)
Kentucky (16)
Louisiana (11)
Maine (67)
Maryland (735)
Massachusetts (3839)
Michigan (209)
Minnesota (342)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (22)
Nevada (55)
New Hampshire (66)
New Jersey (1528)
New Mexico (30)
New York (1569)
North Carolina (924)
North Dakota (8)
Northern California (2200)
Ohio (181)
Oklahoma (13)
Oregon (32)
Pennsylvania (1081)
Puerto Rico (10)
Rhode Island (26)
South America (1129)
South Carolina (19)
South Dakota (1)
Southern California (1928)
Tennessee (95)
Texas (759)
Utah (137)
Virginia (129)
Washington D.C. (56)
Washington State (515)
West Virginia (3)
Wisconsin (55)
686,703 Results for "small business innovation research sbir".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Soaak Technologies Awarded Phase I Small Business Innovation Research (SBIR) Contract from the U.S. Air Force
Soaak Technologies, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) contract from the U.S. Air Force (USAF) for 2023.
July 20, 2023
·
5 min read
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Press Releases
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million
March 27, 2025
·
2 min read
Drug Development
Traverse Biotech Awarded Phase I SBIR Grant by the National Institute of Allergy and Infectious Diseases for Development of Innate Immune Stimulator
Traverse Biotech, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.
May 1, 2024
·
1 min read
Pharm Country
L2P Research Labs Awarded NIH SBIR Grant for Arthritis, Musculoskeletal and Skin Diseases Research
L2P Research, LLC, a leading preclinical CRO, today announced the award of a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).
October 27, 2023
·
1 min read
Drug Development
Starlight Cardiovascular Awarded $2M NIH SBIR Phase II Grant to Develop Pediatric Cardiology Device
Starlight Cardiovascular, Inc., a company developing pediatric cardiovascular medical devices, announced that it has been awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to advance development of its Pulmonary Flow Restrictor.
May 1, 2024
·
2 min read
Genetown
Fluent BioSciences awarded NIH SBIR grant to commercialize low-cost million-cell transcriptome profiling kits powered by Ultima Genomics sequencing, prototype kits now shipping
Fluent BioSciences is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical Sciences (NIGMS, 2 R44 GM137648).
March 21, 2024
·
3 min read
Sarcomatrix Therapeutics Corp.’s Exclusive Research Partner Strykagen Awarded SBIR Phase 2 Grant from the National Institutes of Health (NIH) to Advance Small Molecules Promoting Muscle Regeneration
Strykagen Corp. announced today that it was awarded a $958,973 (of a total $1,953,245) Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH) to conduct Investigational New Drug (IND) enabling studies for S-969, a first-in-class small molecule that may halt or reverse muscle wasting diseases, like muscular dystrophies, cachexia and sarcopenia.
September 20, 2023
·
2 min read
Opinion
Fixing the IRA’s Pill Penalty Is Critical to Supporting Small Molecule Innovation
Price-negotiation provisions that are out of step with reality are discouraging funders and Big Pharma partners from investing in potentially transformative therapies. Fixing some of the unintended consequences of the IRA will clear the way for innovative medicines to reach patients in need.
February 25, 2025
·
6 min read
·
Thomas M. Kaiser
BioForest
AVM Biotechnology Announces that the National Cancer Institute has selected AVM Biotechnology as a Showcase Company for their 2023-2024 Small Business Innovation Research (SBIR) Investor Initiatives
AVM Biotechnology has been selected as a 2023-2024 National Cancer Institute showcase company for the SBIR Investor Initiatives.
August 9, 2023
·
7 min read
1 of 68,671
Next
